Intraplacental Gene Therapy with Ad-IGF-1 Corrects Naturally Occurring Rabbit Model of Intrauterine Growth Restriction

Human Gene Therapy

Volumn 26, Issue 3, 2015, Pages 172-182

  Keswani, Sundeep G ^a,b   Balaji, Swathi ^a   Katz, Anna B ^b   King, Alice ^a   Omar, Khaled ^a   Habli, Mounira ^a   Klanke, Charles ^a   Crombleholme, Timothy M ^a,b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DOSE ESCALATION; FEMALE; FETOPLACENTAL UNIT; FETUS; FETUS WEIGHT; INTRAUTERINE GROWTH RETARDATION; LIVER WEIGHT; LUNG WEIGHT; MALE; MUSCULOSKELETAL SYSTEM; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PLACENTA INSUFFICIENCY; PLACENTA WEIGHT; PROTEIN EXPRESSION; THIRD TRIMESTER PREGNANCY; TRANSPLACENTAL DRUG ADMINISTRATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ADENOVIRIDAE; ANIMAL; DRUG EFFECTS; FETAL GROWTH RETARDATION; GENE THERAPY; GENE TRANSFER; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; LIVER; LUNG; METABOLISM; ORGAN SIZE; PLACENTA; PREGNANCY; PROCEDURES; RABBIT; SKELETAL MUSCLE;

ADENOVIRIDAE; MURINAE; ORYCTOLAGUS CUNICULUS;

ADENOVIRIDAE; ANIMALS; FEMALE; FETAL GROWTH RETARDATION; FETUS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HEART; INSULIN-LIKE GROWTH FACTOR I; LIVER; LUNG; MUSCLE, SKELETAL; ORGAN SIZE; PLACENTA; PLACENTAL INSUFFICIENCY; PREGNANCY; RABBITS;

EID: 84924965534     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2014.065     Document Type: Article

References (48)

1. Cerdeira AS, Kopcow HD, and Karumanchi SA. Regulatory T cells in preeclampsia: some answers, more questions? Am J Pathol 2012;181:1900-1902.
2. Kramer MS, and Kakuma R. Energy and protein intake in pregnancy. Cochrane Database Syst Rev 2003:CD000032.
3. Faraci M, Renda E, Monte S, et al. Fetal growth restriction: current perspectives. J Prenat Med 2011;5:31-33.
4. Barker DJ, Bagby SP, and Hanson MA. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2006;2:700-707.
5. Barker DJ, Gelow J, Thornburg K, et al. The early origins of chronic heart failure: impaired placental growth and initiation of insulin resistance in childhood. Eur J Heart Fail 2010;12:819-825.
6. Barker DJ, Osmond C, Golding J, et al. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 1989;298:564-567.
7. Painter RC, Roseboom TJ, Van Montfrans GA, et al. Microalbuminuria in adults after prenatal exposure to the Dutch famine. J Am Soc Nephrol 2005;16:189-194.
8. Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31-38.
9. Kahn SE, Hull RL, and Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846.
10. Ozanne SE, Fernandez-Twinn D, and Hales CN. Fetal growth and adult diseases. Semin Perinatol 2004;28:81-87.
11. Park JH, Stoffers DA, Nicholls RD, et al. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 2008;118:2316.
12. Simmons RA. Developmental origins of beta-cell failure in type 2 diabetes: the role of epigenetic mechanisms. Pediatr Res 2007;61:64R-67R.
13. Cottrell EC, and Ozanne SE. Early life programming of obesity and metabolic disease. Physiol Behav 2008;94:17-28.
14. Myrie SB, Mcknight LL, Van Vliet BN, et al. Low birth weight is associated with reduced nephron number and increased blood pressure in adulthood in a novel spontaneous intrauterine growth-restricted model in Yucatan miniature swine. Neonatology 2011;100:380-386.
15. Owens JA, Gatford KL, De Blasio MJ, et al. Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth. J Physiol 2007;584:935-949.
16. Painter RC, Roseboom TJ, and Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 2005;20:345-352.
17. Vidal AC, Murphy SK, Murtha AP, et al. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) 2013;37:907-913.
18. Battaglia C, Artini PG, D'Ambrogio G, et al. Maternal hyperoxygenation in the treatment of intrauterine growth retardation. Am J Obstet Gynecol 1992;167:430-435.
19. Vidal AC, Murtha AP, Murphy SK, et al. Maternal BMI, IGF-I levels, and birth weight in African American and white infants. Int J Pediatr 2013;2013:191472.
20. Vidal AC, Henry NM, Murphy SK, et al. PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. Clin Transl Oncol 2014;16:266-272.
21. Fall CH, Pandit AN, Law CM, et al. Size at birth and plasma insulin-like growth factor-1 concentrations. Arch Dis Child 1995;73:287-293.
22. Habli M, Jones H, Aronow B, et al. Recapitulation of characteristics of human placental vascular insufficiency in a novel mouse model. Placenta 2013;34:1150-1158.
23. Nishimura Y, Ii M, Qin G, et al. CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol 2012;132:711-720.
24. Carr DJ, Wallace JM, Aitken RP, et al. Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies. Hum Gene Ther 2014;25:375-384.
25. Rana S, Schnettler WT, Powe C, et al. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy 2013;32:189-201.
26. Sferruzi-Perri AN, Owens JA, Standen P et al. Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term. Am J Physiol Endocrinol Metabol 2007;292:E668-E676.
27. Darp RA, De Boo HA, Phua HH, et al. Differential regulation of igf1 and igf1r mRNA levels in the two hepatic lobes following intrauterine growth restriction and its treatment with intra-amniotic insulin-like growth factor-1 in ovine fetuses. Reprod Fertil Dev 2010;22:1188-1197.
28. Jones HN, Crombleholme T, and Habli M. Adenoviral-mediated placental gene transfer of IGF-1 corrects placental insufficiency via enhanced placental glucose transport mechanisms. PLoS One 2013;8:e74632.
29. Buchmiller-Crair TL, Gregg JP, Rivera FA, Jr., et al. Delayed disaccharidase development in a rabbit model of intrauterine growth retardation. Pediatr Res 2001;50:520-524.
30. Morrison JL. Sheep models of intrauterine growth restriction: fetal adaptations and consequences. Clin Exp Pharmacol Physiol 2008;35:730-743.
31. Thornburg KL. Fetal response to intrauterine stress. Ciba Found Symp 1991;156:17-29; discussion 29-37.
32. Jones H, Crombleholme T, and Habli M. Regulation of amino acid transporters by adenoviral-mediated human insulin-like growth factor-1 in a mouse model of placental insufficiency in vivo and the human trophoblast line BeWo in vitro. Placenta 2014;35:132-138.
33. Schiaffino S, and Mammucari C. Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models. Skelet Muscle 2011;1:4.
34. Velloso CP. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 2008;154:557-568.
35. Cerdeira AS, Rajakumar A, Royle CM, et al. Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol 2013;190:3939-3948.
36. Mühlhäusler B, Adam CL, Marrocco E, et al. Impact of glucose infusion on the structural and functional characteristics of adipose tissue and on hypothalamic gene expression for appetite regulatory neuropeptides in the sheep fetus during late gestation. J Physiol 2005;565:185-195.
37. Dumortier O, Blondeau B, Duvillie B, et al. Different mechanisms operating during different critical time-windows reduce rat fetal beta cell mass due to a maternal low-protein or low-energy diet. Diabetologia 2007;50:2495-2503.
38. Nyirenda MJ, Lindsay RS, Kenyon CJ, et al. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998;101:2174.
39. McMillen IC, and Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005;85:571-633.
40. Simmons RA, Templeton LJ, and Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001;50:2279-2286.
41. Arroyo JA, and Winn VD. Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol 2008;32:172-177.
42. Cerdeira AS, and Karumanchi SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med 2012;2:pii:a006585.
43. Cellini C, Xu J, Arriaga A, et al. Effect of epidermal growth factor infusion on fetal rabbit intrauterine growth retardation and small intestinal development. J Pediatr Surg 2004;39:891-897; discussion 891-897.
44. Borzsonyi B, Demendi C, Rigo J, Jr., et al. The regulation of apoptosis in intrauterine growth restriction: a study of Bcl-2 and Bax gene expression in human placenta. J Matern Fetal Neonatal Med 2013;26:347-350.
45. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol 2003;21:117-122.
46. Dumasius V, Jameel M, Burhop J, et al. In vivo timing of onset of transgene expression following adenoviral-mediated gene transfer. Virology 2003;308:243-249.
47. Fisher KD, Stallwood Y, Green NK, et al. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther 2001;8:341-348.
48. Rana S, Cerdeira AS, Wenger J, et al. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One 2012;7:e48259.